COMMUNIQUÉS West-GlobeNewswire

VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
17/01/2018
Two-part Phase 1/2a study of VBI-1901 to enroll patients with recurrent GBM Part A: Dose escalation to enroll up to 18 patients Part B: Subsequent extension of optimal dose to enroll up to 10 additional patients [...]
Inovio’s Co-Founder along with its Lead Antigen Designer Named Among Top 20 Researchers With Most Granted U.S Patents for 2016
17/01/2018
PLYMOUTH MEETING, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Dr. David B. Weiner, its co-founder; and Dr. Jian Yan, the company’s Lead Antigen Designer, have [...]
BeyondSpring to Present Data from Phase 2 Portion of Study 105 Phase 2/3 Trial with Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
17/01/2018
NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced [...]
Dentsply Sirona Announces the Addition of New Board Members
17/01/2018
YORK, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the size of its Board of Directors has been increased from nine [...]
BIOLIFE4D Targets High Growth Healthcare 3D Printing Market as it Readies for Regulation A+ Offering
17/01/2018
CHICAGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the high growth healthcare 3D [...]
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2017 Results
17/01/2018
BRISBANE, Calif., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will [...]
Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona Inc.
17/01/2018
YORK, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that its Board of Directors has appointed Donald M. Casey Jr. as [...]
Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
17/01/2018
- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and Resistance Mechanisms RUTHERFORD, N.J., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX [...]
Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial with Increased Sample Size Following Promising Interim Analysis
17/01/2018
Independent Data Monitoring Committee (DMC) recommends continuation of INSPIRE trial with trial expansion per adaptive design based on interim analysis results for overall survival Trial Executive Committee unanimously [...]
Arcturus Therapeutics Announces Expansion of Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH) and Other GI Disorders
17/01/2018
SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, announced today that it is extending its partnership with Takeda Pharmaceutical Company Limited ( [...]
NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology
17/01/2018
WALTHAM, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today a collaboration with GlaxoSmithKline (NYSE: GSK ), one of the world's largest science-led global healthcare companies, [...]
Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
17/01/2018
~ MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder ~ ~ MACRILEN is Strongbridge’s Second Commercial Product; Expands the [...]
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen™ (macimorelin) in the U.S. and Canada
17/01/2018
CHARLESTON, S.C., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) announced today that it has, through a wholly-owned subsidiary, entered into a license and assignment agreement with [...]
Natus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7th
17/01/2018
PLEASANTON, Calif., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that the Company will release its 2017 fourth quarter financial results before the market opens on [...]
RedHill Biopharma and Express Scripts Subsidiary Inside Rx Add EnteraGam® to Savings Program for Uninsured or Underinsured Patients
17/01/2018
TEL-AVIV, Israel and RALEIGH, N.C., Jan. 17, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Gemphire Completes Patient Enrollment in INDIGO-1 Trial in Severe Hypertriglyceridemia (SHTG) Patients
17/01/2018
On Track to Report Top-Line Data from Phase 2b Trial in Second Quarter of 2018 LIVONIA, Mich., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company [...]
In 2018 “Grindeks” forecasts at least 10% increase in turnover
17/01/2018
Joint Stock Company “Grindeks” informs, it is expecting to reach at least 10% increase in turnover in 2018, comparing with the results of 2017. In 2018, “Grindeks” will strategically focus on complex solutions to meet [...]
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China
17/01/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics, today [...]
OraSure Technologies Earnings Conference Call Invitation
17/01/2018
2017 Fourth Quarter Earnings Conference Call Wednesday, February 7, 2018, 5:00 p.m. ET BETHLEHEM, Pa., Jan. 17, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ) has scheduled its regular earnings [...]

Pages